| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Inflammation Research Unit, School of Pathology, University of New South Wales; and the 2 Department of Ophthalmology, Prince of Wales Hospital, Sydney, New South Wales, Australia.
PURPOSE. Pterygia are invasive, proliferative fibrovascular growths, with the matrix metalloproteinase (MMP) family of enzymes strongly implicated in the pathogenesis of these lesions. The purpose of this study was to determine the cellular distribution and activation status of matrilysin (MMP-7) in pterygia.
METHODS. Resected pterygia (n = 8) and normal conjunctiva (n = 8) were sectioned and analyzed immunohistochemically with two different epitope-specific anti-MMP-7 monoclonal antibodies (Abs) which differentiate pro- and active MMP-7. The specificity of each Ab was confirmed by Western blot analysis of p-aminophenylmercuric acetate (APMA)–activated and latent recombinant MMP-7. Pterygia (n = 4) and autologous normal conjunctiva (n = 4) were placed in organ culture to determine the activation status of secreted MMP-7.
RESULTS. Precursor and active forms of MMP-7 were detected in epithelial cells from both pterygia and normal conjunctiva. Intense immunoreactivity for pro- and active MMP-7 was also observed in the pterygium vasculature, but was essentially absent from conjunctival vessels. Pro-MMP-7 was also identified in the epithelial basement membrane and associated with matrix components in pterygia. The 141-7B2 Ab reacted with the 30-kDa latent MMP-7, and the IM47L Ab precipitated a 19-kDa active enzyme, thus confirming the differential specificity of each Ab. Pro- and active MMP-7 were increased 1.4- and 2.7-fold, respectively, in the supernatants from organ-cultured pterygia compared with conjunctiva.
CONCLUSIONS. This study is the first to specifically localize an active MMP species in pterygia and strengthens the hypothesis that these enzymes are involved in the pathogenesis of this disease. The data also suggest that MMP-7 may play a significant role in the angiogenesis that characterizes this lesion. Future studies will be directed at determining whether targeting MMP activity may be useful for treatment of pterygia.
This article has been cited by other articles:
|
|
 |
|
  N. Kato, S. Shimmura, T. Kawakita, H. Miyashita, Y. Ogawa, S. Yoshida, K. Higa, H. Okano, and K. Tsubota {beta}-Catenin Activation and Epithelial-Mesenchymal Transition in the Pathogenesis of Pterygium Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1511 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Di Girolamo, D. Wakefield, and M. T. Coroneo UVB-Mediated Induction of Cytokines and Growth Factors in Pterygium Epithelial Cells Involves Cell Surface Receptors and Intracellular Signaling. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2430 - 2437. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Di Girolamo, M. Coroneo, and D. Wakefield Epidermal Growth Factor Receptor Signaling Is Partially Responsible for the Increased Matrix Metalloproteinase-1 Expression in Ocular Epithelial Cells after UVB Radiation Am. J. Pathol., August 1, 2005; 167(2): 489 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H. Sachdev, N. Di Girolamo, T. M. Nolan, P. J. McCluskey, D. Wakefield, and M. T. Coroneo Matrix Metalloproteinases and Tissue Inhibitors of Matrix Metalloproteinases in the Human Lens: Implications for Cortical Cataract Formation Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4075 - 4082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Nolan, N. Di Girolamo, M. T. Coroneo, and D. Wakefield Proliferative Effects of Heparin-Binding Epidermal Growth Factor-like Growth Factor on Pterygium Epithelial Cells and Fibroblasts Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 110 - 113. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Di Girolamo, M. T. Coroneo, and D. Wakefield UVB-Elicited Induction of MMP-1 Expression in Human Ocular Surface Epithelial Cells Is Mediated through the ERK1/2 MAPK-Dependent Pathway Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4705 - 4714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Solomon, M. Grueterich, D.-Q. Li, D. Meller, S.-B. Lee, and S. C. G. Tseng Overexpression of Insulin-like Growth Factor-Binding Protein-2 in Pterygium Body Fibroblasts Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Nolan, N. DiGirolamo, N. H. Sachdev, T. Hampartzoumian, M. T. Coroneo, and D. Wakefield The Role of Ultraviolet Irradiation and Heparin-Binding Epidermal Growth Factor-Like Growth Factor in the Pathogenesis of Pterygium Am. J. Pathol., February 1, 2003; 162(2): 567 - 574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kure, J.-H. Chang, T. Kato, E. Hernandez-Quintela, H. Ye, P. C.-S. Lu, L. M. Matrisian, D. Gatinel, S. Shapiro, F. Ghosheh, et al. Corneal Neovascularization after Excimer Keratectomy Wounds in Matrilysin-Deficient Mice Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 137 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Di Girolamo, R. K. Kumar, M. T. Coroneo, and D. Wakefield UVB-Mediated Induction of Interleukin-6 and -8 in Pterygia and Cultured Human Pterygium Epithelial Cells Invest. Ophthalmol. Vis. Sci., November 1, 2002; 43(11): 3430 - 3437. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
